2011
DOI: 10.1158/0008-5472.can-11-0543
|View full text |Cite
|
Sign up to set email alerts
|

Notch Signaling in CD66+ Cells Drives the Progression of Human Cervical Cancers

Abstract: Human epithelial tumor progression and metastasis involve cellular invasion, dissemination in the vasculature, and regrowth at metastatic sites. Notch signaling has been implicated in metastatic progression but its roles have yet to be fully understood. Here we report the important role of Notch signaling in maintaining cells expressing the carcinoembryonic antigen cell adhesion molecule CEACAM (CD66), a known mediator of metastasis. CD66 and Notch1 were studied in clinical specimens and explants of human cerv… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
39
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 32 publications
(44 citation statements)
references
References 47 publications
(54 reference statements)
5
39
0
Order By: Relevance
“…In cervical cancer specifically, investigators have found decreased Notch1 expression (27)(28)(29). Conversely, others have found increased Notch1 expression during cervical cancer development (30)(31)(32) and increased Notch1 expression and activation by the HR E6 and E7 oncogenes (33), which leads to improved cell growth (34,35). Our findings support the positive regulation of Notch1 by 16E6 and NFX1-123.…”
supporting
confidence: 74%
“…In cervical cancer specifically, investigators have found decreased Notch1 expression (27)(28)(29). Conversely, others have found increased Notch1 expression during cervical cancer development (30)(31)(32) and increased Notch1 expression and activation by the HR E6 and E7 oncogenes (33), which leads to improved cell growth (34,35). Our findings support the positive regulation of Notch1 by 16E6 and NFX1-123.…”
supporting
confidence: 74%
“…Such sub-sets often upregulate the expression of pluripotency factors, Oct4, Nanog, Sox2 and cell survival pathways such as Notch Signaling (4,710). We have recently identified a subset of cells in cervical cancers with enhanced tumorigenic and metastatic functions (10). These cells are sustained by Notch signaling and are distinct in their expression of CD66.…”
Section: Introductionmentioning
confidence: 99%
“…The transmembrane protein CD66, a member of the carcinoembryonic antigen family, has been implicated in invasive functions in different solid tumours, including ovarian cancer and estrogen deprived breast cancer cells (1114). CD66+ cells in cervical cancers have higher expression of the pluripotency factors Oct4 and Nanog, as well as drug transporters (10). Other groups have reported CD49f, a marker of basal undifferentiated keratinocytes, Sox2, one of the induced pluripotency genes and CD44+ Cytokeratin 17+ subsets to be linked to tumourigenic traits and sub-sets in cervical cancer (15,16).…”
Section: Introductionmentioning
confidence: 99%
“…29 Of the protein encoding transcripts upregulated in all three cultures, the cell adhesion molecules CEACAM5 and EPCAM have both been linked to migration, invasion and/or metastasis in numerous cancer types 35,36 and have further been associated with Notch signaling in human cervical cancers and pancreatic tumors, where Notch inhibition resulted in downregulation of CEACAM5 and EPCAM respectively. 37,38 A correlation between CEACAM5/EPCAM and Notch in GBM has yet to be reported. However, our results suggest that the correlation is in opposite as compared with cervical and pancreatic cancer as we found these cell adhesion molecules to be upregulated upon Notch inhibition.…”
Section: Discussionmentioning
confidence: 99%